MD Anderson launches new Strategy and...
The University of Texas MD Anderson Cancer Center today launched a pivotal, multi-year Strategy aimed at making the greatest impact on humanity in the institution’s work to end cancer. Developed with direct involvement from front-line cancer fighters and through ideas curated from gifted and talented faculty, MD Anderson’s new Strategy is anchored in its mission and grounded in its unwavering commitment to stakeholders in Texas,...
Study defines small-cell lung cancer subtypes and distinct...
Researchers from The University of Texas MD Anderson Cancer Center have developed the first comprehensive framework to classify...
Robin Roberts, Charles Barkley and TNT's Ernie Johnson Jr. team up...
An all-star lineup of basketball greats, several of whom are courageous cancer survivors, will share their stories Feb. 4 at The...
New computational tool reliably differentiates between cancer and...
In an effort to address a major challenge when analyzing large single-cell RNA-sequencing datasets, researchers from The University of...
MD Anderson and UroGen Pharma announce strategic research...
The University of Texas MD Anderson Cancer Center and UroGen Pharma Ltd. today announced a strategic three-year collaboration...
Mediterranean diet may decrease risk of prostate cancer...
In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from...
MD Anderson and Xencor enter strategic collaboration to...
The University of Texas MD Anderson Cancer Center and Xencor, Inc. today announced a strategic research collaboration and...
Single-cell analysis of metastatic gastric cancer finds...
Researchers from The University of Texas MD Anderson Cancer Center who profiled more than 45,000 individual cells from patients with...
Immunology study finds protein critical to T cell...
Researchers at The University of Texas MD Anderson Cancer Center have discovered that a protein called NF-kappa B-inducing kinase...